Peptide.com

Metadescription Contemporary, prostate cancer has become one of the diseases that threaten the physical and mental health of men. Early prevention and treatment are necessary to treat this disease.  Degarelix powder  is an effective drug for the treatment of prostate cancer, and we should take the initiative to understand some important information about it so that we can use it properly and safely. 1. What is Degarelix? Degarelix  (214766-78-6) is a hormone therapy drug that minimizes the amount of hormones in the body, including testosterone. It is classified under a class of medications known as gonadotropin-releasing hormone (GnRH) receptor antagonists. This synthetic peptide derivative drug is known by its brand name “Firmagon”. The following are its specifications: Drug Class: GnRH Analogue; GnRH antagonist; Antigonadotropin Chemical Formula: C82H103ClN18O16 Molar Mass: 1630.75 g/mol g·mol−1 Bioavailability: 30-40% Routes of Administration: Subcutaneou...

1.  What is Degarelix? Degarelix powder is used for the treatment of advanced prostate cancer. It sold under the brand name Firmagon among others. Degarelix powder  (214766-78-6) is a synthetic peptide derivative powder, degarelix peptide sequence is Ac-D2Nal-D4Cpa-D3Pal-Ser-4Aph(L-Hor)-D4Aph(Cbm)-Leu-Lys(Ipr)-Pro-DAla-NH2. Degarelix binds to gonadotropin-releasing hormone (GnRH) receptors in the pituitary gland and blocks interaction with GnRH. This antagonism reduces luteinising hormone (LH) and follicle-stimulating hormone (FSH) which ultimately causes testosterone suppression. Reduction in testosterone is important in treating men with advanced prostate cancer. 2.  D egarelix mechanism of action Degarelix is a GnRH antagonist. In general, an antagonist drug blocks the receptor by binding to it and counteracts its function. Degarelix inhibits GnRH from binding to its receptors and stops the release of gonadotropin. By blocking the GnRH receptors, degarelix i...